Low disability accumulation after 4-year ocrelizumab therapy in treatment-naive patients with early-stage relapsing-remitting multiple sclerosis; data from the Phase IIIb ENSEMBLE study

Patti F., Bermel R., Brochet B., Berger T., Carroll W., Freedman M. S., ...More

9th Joint ECTRIMS-ACTRIMS meeting, Milan, Italy, 11 - 13 October 2023, pp.594-596, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • City: Milan
  • Country: Italy
  • Page Numbers: pp.594-596
  • Hacettepe University Affiliated: Yes